{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:58:27Z","timestamp":1791316707115,"version":"4.3.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["Cancer Research UK"],"award-info":[{"award-number":["Cancer Research UK"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000015","name":"Canadian Cancer Society Research Institute","doi-asserted-by":"publisher","award":["Canadian Cancer Society Research Institute"],"award-info":[{"award-number":["Canadian Cancer Society Research Institute"]}],"id":[{"id":"10.13039\/501100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004897","name":"European Organisation for Research and Treatment of Cancer","doi-asserted-by":"publisher","award":["European Organisation for Research and Treatment of Cancer"],"award-info":[{"award-number":["European Organisation for Research and Treatment of Cancer"]}],"id":[{"id":"10.13039\/501100004897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00259-026-07812-7","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T06:04:23Z","timestamp":1773036263000},"page":"4944-4954","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluating the prognostic impact of multiple 18FDG-PET imaging parameters in small-cell lung cancer: Insights from the long-term analysis of the CONVERT trial"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5234-2315","authenticated-orcid":false,"given":"Anubhav","family":"Datta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Spiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitesh","family":"Mistry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Julyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James PB","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Faivre-Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5155-2310","authenticated-orcid":false,"given":"Prakash","family":"Manoharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"7812_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/J.JTHO.2022.10.002","volume":"18","author":"Q Wang","year":"2023","unstructured":"Wang Q, G\u00fcm\u00fc\u015f ZH, Colarossi C, Memeo L, Wang X, Kong CY, et al. SCLC: Epidemiology, risk Factors, genetic Susceptibility, molecular Pathology, Screening, and early detection. J Thorac Oncol Elsevier. 2023;18:31\u201346. https:\/\/doi.org\/10.1016\/J.JTHO.2022.10.002.","journal-title":"J Thorac Oncol Elsevier"},{"key":"7812_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/S41572-020-00235-0","volume":"7","author":"CM Rudin","year":"2021","unstructured":"Rudin CM, Brambilla E, Faivre-Finn C, Sage J. Small-cell lung cancer. Nat Rev Dis Primer Nat Res. 2021;7:3\u20133. https:\/\/doi.org\/10.1038\/S41572-020-00235-0.","journal-title":"Nat Rev Dis Primer Nat Res"},{"key":"7812_CR3","doi-asserted-by":"publisher","unstructured":"Sivakumar S, Moore JA, Montesion M, Sharaf R, Lin DI, Col\u00f3n CI, et al. Integrative Analysis of a Large Real-World Cohort of Small Cell Lung Cancer Identifies Distinct Genetic Subtypes and Insights into Histologic Transformation. Cancer Discov Am Association Cancer Res Inc. 2023;13:1572\u201391 https:\/\/doi.org\/10.1158\/2159-8290.CD-22-0620\/725173\/.AM\/INTEGRATIVE-ANALYSIS-OF-A-LARGE-REAL-WORLD-COHORT.\u00a0","DOI":"10.1158\/2159-8290.CD-22-0620\/725173\/"},{"key":"7812_CR4","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.6004\/JNCCN.2021.0058","volume":"19","author":"AKP Ganti","year":"2021","unstructured":"Ganti AKP, Loo BW, Bassetti M, Blakely C, Chiang A, D\u2019Amico TA, et al. Small cell lung cancer, version 2.2022, NCCN clinical practice guidelines in Oncology. J Natl Compr cancer Netw JNCCN. J Natl Compr Canc Netw. 2021;19:1441\u201364. https:\/\/doi.org\/10.6004\/JNCCN.2021.0058.","journal-title":"J Natl Compr Canc Netw"},{"key":"7812_CR5","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1056\/NEJMOA2404873","volume":"391","author":"Y Cheng","year":"2024","unstructured":"Cheng Y, Spigel DR, Cho BC, Laktionov KK, Fang J, Chen Y, et al. Durvalumab after chemoradiotherapy in Limited-Stage Small-Cell lung cancer. N Engl J Med Mass Med Soc. 2024;391:1313\u201327. https:\/\/doi.org\/10.1056\/NEJMOA2404873.","journal-title":"N Engl J Med Mass Med Soc"},{"key":"7812_CR6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4103\/0971-3026.155831","volume":"25","author":"NC Purandare","year":"2015","unstructured":"Purandare NC, Rangarajan V. Imaging of lung cancer: implications on staging and management. Indian J Radiol Imaging Wolters Kluwer Medknow Publications. 2015;25:109\u2013109. https:\/\/doi.org\/10.4103\/0971-3026.155831.","journal-title":"Indian J Radiol Imaging Wolters Kluwer Medknow Publications"},{"key":"7812_CR7","first-page":"31","volume":"4","author":"M Zelen","year":"1973","unstructured":"Zelen M. Keynote address on biostatistics and data retrieval. Cancer Chemother Rep. 1973;4:31\u201342. https:\/\/www.scirp.org\/reference\/referencespapers?referenceid=1281442. - References - Scientific Research Publishing.","journal-title":"Cancer Chemother Rep"},{"key":"7812_CR8","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1097\/JTO.0b013e31815bdc0d","volume":"2","author":"FA Shepherd","year":"2007","unstructured":"Shepherd FA, Crowley J, Van Houtte P, Postmus PE, Carney D, Chansky K, et al. The international association for the study of lung cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer. J Thorac Oncol Lippincott Williams Wilkins. 2007;2:1067\u201377. https:\/\/doi.org\/10.1097\/JTO.0b013e31815bdc0d.","journal-title":"J Thorac Oncol Lippincott Williams Wilkins"},{"key":"7812_CR9","doi-asserted-by":"publisher","first-page":"e185335","DOI":"10.1001\/JAMAONCOL.2018.5335","volume":"5","author":"A Salem","year":"2019","unstructured":"Salem A, Mistry H, Hatton M, Locke I, Monnet I, Blackhall F, et al. Association of chemoradiotherapy with outcomes among patients with stage I to II vs stage III small cell lung cancer: secondary analysis of a randomized clinical trial. JAMA Oncol Am Med Association. 2019;5:e185335\u2013185335. https:\/\/doi.org\/10.1001\/JAMAONCOL.2018.5335.","journal-title":"JAMA Oncol Am Med Association"},{"key":"7812_CR10","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jtcvs.2017.08.138","volume":"155","author":"FC Detterbeck","year":"2018","unstructured":"Detterbeck FC. The eighth edition TNM stage classification for lung cancer: what does it mean on main street? J Thorac Cardiovasc Surg. 2018;155:356\u20139. https:\/\/doi.org\/10.1016\/j.jtcvs.2017.08.138.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"7812_CR11","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/J.JTHO.2022.02.008","volume":"17","author":"FC Detterbeck","year":"2022","unstructured":"Detterbeck FC, Nishimura KK, Cilento VJ, Giuliani M, Marino M, Osarogiagbon RU, et al. The international association for the study of lung cancer staging project: methods and guiding principles for the development of the ninth edition TNM Classification. J thorac oncol off publ int assoc study lung cancer. J Thorac Oncol. 2022;17:806\u201315. https:\/\/doi.org\/10.1016\/J.JTHO.2022.02.008.","journal-title":"J Thorac Oncol"},{"key":"7812_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/J.LUNGCAN.2011.03.013","volume":"73","author":"D Thomson","year":"2011","unstructured":"Thomson D, Hulse P, Lorigan P, Faivre-Finn C. The role of positron emission tomography in management of small cell lung cancer. Lung Cancer Elsevier. 2011;73:121\u20136. https:\/\/doi.org\/10.1016\/J.LUNGCAN.2011.03.013.","journal-title":"Lung Cancer Elsevier"},{"key":"7812_CR13","doi-asserted-by":"publisher","unstructured":"Martucci F, Pascale M, Valli MC, Pesce GA, Froesch P, Giovanella L, et al. Impact of 18F-FDG PET\/CT in staging patients with small cell lung cancer: A systematic review and Meta-Analysis. Front Med [Internet] Front Med (Lausanne). 2020;6. https:\/\/doi.org\/10.3389\/FMED.2019.00336.","DOI":"10.3389\/FMED.2019.00336"},{"key":"7812_CR14","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/J.JTHO.2019.03.023","volume":"14","author":"P Manoharan","year":"2019","unstructured":"Manoharan P, Salem A, Mistry H, Gornall M, Harden S, Julyan P, et al. 18F-Fludeoxyglucose PET\/CT in SCLC: analysis of the CONVERT randomized controlled trial. J Thorac Oncol Elsevier Inc. 2019;14:1296\u20131296. https:\/\/doi.org\/10.1016\/J.JTHO.2019.03.023.","journal-title":"J Thorac Oncol Elsevier Inc"},{"key":"7812_CR15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3390\/DIAGNOSTICS11020174","volume":"11","author":"TN Christensen","year":"2021","unstructured":"Christensen TN, Andersen PK, Langer SW, Fischer BMB. Prognostic value of 18F\u2013FDG\u2013PET parameters in patients with small cell lung cancer: A Meta-Analysis and review of current Literature. Diagn 2021 11 page 174. Multidisciplinary Digit Publishing Inst. 2021;11:174\u2013174. https:\/\/doi.org\/10.3390\/DIAGNOSTICS11020174.","journal-title":"Multidisciplinary Digit Publishing Inst"},{"key":"7812_CR16","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.1200\/JCO.2007.14.3065","volume":"26","author":"JV Frangioni","year":"2008","unstructured":"Frangioni JV. New technologies for human cancer imaging. J clin oncol off J am Soc clin oncol. J Clin Oncol. 2008;26:4012\u201321. https:\/\/doi.org\/10.1200\/JCO.2007.14.3065.","journal-title":"J Clin Oncol"},{"key":"7812_CR17","doi-asserted-by":"publisher","unstructured":"Lawrence R, Watters M, Davies CR, Pantel K, Lu YJ. Circulating tumour cells for early detection of clinically relevant cancer. Nat Rev Clin Oncol 2023 207. Nature Publishing Group; 2023;20:487\u2013500. https:\/\/doi.org\/10.1038\/s41571-023-00781-y","DOI":"10.1038\/s41571-023-00781-y"},{"key":"7812_CR18","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1093\/ANNONC\/MDS138","volume":"23","author":"TJN Hiltermann","year":"2012","unstructured":"Hiltermann TJN, Pore MM, Van den Berg A, Timens W, Boezen HM, Liesker JJW, et al. Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor. Ann Oncol Elsevier. 2012;23:2937\u201342. https:\/\/doi.org\/10.1093\/ANNONC\/MDS138.","journal-title":"Ann Oncol Elsevier"},{"key":"7812_CR19","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1093\/ANNONC\/MDZ122","volume":"30","author":"RY Tay","year":"2019","unstructured":"Tay RY, Fern\u00e1ndez-Guti\u00e9rrez F, Foy V, Burns K, Pierce J, Morris K, et al. Prognostic value of Circulating tumour cells in limited-stage small-cell lung cancer: analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) randomised controlled trial. Ann Oncol Elsevier. 2019;30:1114\u201320. https:\/\/doi.org\/10.1093\/ANNONC\/MDZ122.","journal-title":"Ann Oncol Elsevier"},{"key":"7812_CR20","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/S1470-2045(17)30318-2","volume":"18","author":"C Faivre-Finn","year":"2017","unstructured":"Faivre-Finn C, Snee M, Ashcroft L, Appel W, Barlesi F, Bhatnagar A, et al. Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial. Lancet Oncol Lancet Publishing Group. 2017;18:1116\u201325. https:\/\/doi.org\/10.1016\/S1470-2045(17)30318-2.","journal-title":"Lancet Oncol Lancet Publishing Group"},{"key":"7812_CR21","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1097\/JTO.0B013E31812F3C1A","volume":"2","author":"P Goldstraw","year":"2007","unstructured":"Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, et al. The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J thorac oncol off publ int assoc study lung cancer. J Thorac Oncol. 2007;2:706\u201314. https:\/\/doi.org\/10.1097\/JTO.0B013E31812F3C1A.","journal-title":"J Thorac Oncol"},{"key":"7812_CR22","doi-asserted-by":"publisher","first-page":"S122","DOI":"10.2967\/JNUMED.108.057307","volume":"50","author":"RL Wahl","year":"2009","unstructured":"Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med Soc Nuclear Med. 2009;50:S122\u201350. https:\/\/doi.org\/10.2967\/JNUMED.108.057307.","journal-title":"J Nucl Med Soc Nuclear Med"},{"key":"7812_CR23","doi-asserted-by":"publisher","first-page":"S1074","DOI":"10.1016\/j.annonc.2023.09.1253","volume":"34","author":"L Landi","year":"2023","unstructured":"Landi L, Resuli B, D\u2019Incecco A, Tufman A, Cannita K, Minuti G, et al. 2022P ALBA project: prognostic impact of laterality in small cell lung cancer. Ann Oncol Elsevier BV. 2023;34:S1074\u20131074. https:\/\/doi.org\/10.1016\/j.annonc.2023.09.1253.","journal-title":"Ann Oncol Elsevier BV"},{"key":"7812_CR24","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1007\/S00259-004-1606-X","volume":"31","author":"I Brink","year":"2004","unstructured":"Brink I, Schumacher T, Mix M, Ruhland S, Stoelben E, Digel W, et al. Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer. Eur J Nucl Med Mol Imaging Eur J Nucl Med Mol Imaging. 2004;31:1614\u201320. https:\/\/doi.org\/10.1007\/S00259-004-1606-X.","journal-title":"Eur J Nucl Med Mol Imaging Eur J Nucl Med Mol Imaging"},{"key":"7812_CR25","volume-title":"Lung cancer: diagnosis and management [Internet]","author":"National Institute for Health and Care Excellence","year":"2019","unstructured":"National Institute for Health and Care Excellence. Lung cancer: diagnosis and management [Internet]. London: National Institute for Health and Care Excellence; 2019. Report No.: NICE guideline NG122. https:\/\/www.nice.org.uk\/guidance\/ng122."},{"key":"7812_CR26","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cllc.2015.07.004","volume":"17","author":"LT Ong","year":"2016","unstructured":"Ong LT, Dunphy M, Foster A, Woo KM, Zhang Z, Perez C, et al. Prognostic value of pre radiotherapy 18F-FDG PET\/CT volumetrics in Limited-stage small cell lung cancer. Clin Lung Cancer. 2016;17:184\u20138. https:\/\/doi.org\/10.1016\/j.cllc.2015.07.004.","journal-title":"Clin Lung Cancer"},{"key":"7812_CR27","doi-asserted-by":"publisher","first-page":"e2772","DOI":"10.1097\/MD.0000000000002772","volume":"95","author":"SH Kwon","year":"2016","unstructured":"Kwon SH, Hyun SH, Yoon J-K, An Y-S, Oh Y-T, Choi J-H, et al. The highest metabolic activity on FDG PET is associated with overall survival in Limited-Stage Small-Cell lung cancer. Med (Baltim). 2016;95:e2772. https:\/\/doi.org\/10.1097\/MD.0000000000002772.","journal-title":"Med (Baltim)"},{"key":"7812_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00259-017-3740-2","volume":"44","author":"N Aide","year":"2017","unstructured":"Aide N, Lasnon C, Veit-Haibach P, Sera T, Sattler B, Boellaard R. EANM\/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies. Eur J Nucl Med Mol Imaging. 2017;44:17\u201331. https:\/\/doi.org\/10.1007\/s00259-017-3740-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7812_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12149-022-01820-x","volume":"37","author":"G Akamatsu","year":"2023","unstructured":"Akamatsu G, Tsutsui Y, Daisaki H, Mitsumoto K, Baba S, Sasaki M. A review of harmonization strategies for quantitative PET. Ann Nucl Med. 2023;37:71\u201388. https:\/\/doi.org\/10.1007\/s12149-022-01820-x.","journal-title":"Ann Nucl Med"},{"key":"7812_CR30","doi-asserted-by":"publisher","first-page":"108827","DOI":"10.1016\/J.COMPBIOMED.2024.108827","volume":"179","author":"A Stefano","year":"2024","unstructured":"Stefano A. Challenges and limitations in applying radiomics to PET imaging: possible opportunities and avenues for research. Comput Biol Med Pergamon. 2024;179:108827\u2013108827. https:\/\/doi.org\/10.1016\/J.COMPBIOMED.2024.108827.","journal-title":"Comput Biol Med Pergamon"},{"key":"7812_CR31","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/S12885-024-11862-1","volume":"24","author":"J Wu","year":"2024","unstructured":"Wu J, Zhou Y, Xu C, Yang C, Liu B, Zhao L, et al. Effectiveness of CT radiomic features combined with clinical factors in predicting prognosis in patients with limited-stage small cell lung cancer. BMC Cancer BioMed Cent Ltd. 2024;24:170\u2013170. https:\/\/doi.org\/10.1186\/S12885-024-11862-1.","journal-title":"BMC Cancer BioMed Cent Ltd"},{"key":"7812_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/S41598-024-73331","volume":"14","author":"F Wang","year":"2024","unstructured":"Wang F, Chen W, Chen F, Lu J, Xu Y, Fang M, et al. Risk stratification and overall survival prediction in extensive stage small cell lung cancer after chemotherapy with immunotherapy based on CT radiomics. Sci Rep Nat Res. 2024;14:1\u20138. https:\/\/doi.org\/10.1038\/S41598-024-73331-W ;SUBJMETA=250,631,67;KWRD=CANCER,IMMUNOLOGY.","journal-title":"Sci Rep Nat Res"},{"key":"7812_CR33","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/S11604-025-01742-4","volume":"43","author":"M Peng","year":"2025","unstructured":"Peng M, Wang M, An W, Wu T, Zhang Y, Ge F, et al. Predictive classification of lung cancer pathological based on PET\/CT radiomics. Jpn J Radiol Springer. 2025;43:1007\u201324. https:\/\/doi.org\/10.1007\/S11604-025-01742-4.","journal-title":"Jpn J Radiol Springer"},{"key":"7812_CR34","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.ijrobp.2024.02.063","volume":"119","author":"GM Walls","year":"2024","unstructured":"Walls GM, Mistry H, Barlesi F, Bezjak A, Pechoux CL, O\u2019Brien M, et al. Long-Term outcomes after concurrent Once- or Twice-Daily chemoradiation in Limited-Stage small cell lung cancer: A brief report from the CONVERT trial. Int J Radiat Oncol Biol Phys Elsevier Inc. 2024;119:1386\u201390. https:\/\/doi.org\/10.1016\/j.ijrobp.2024.02.063.","journal-title":"Int J Radiat Oncol Biol Phys Elsevier Inc"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07812-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-07812-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07812-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:36:22Z","timestamp":1781638582000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-026-07812-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["7812"],"URL":"https:\/\/doi.org\/10.1007\/s00259-026-07812-7","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"30 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The CONVERT trial is registered on ClinicalTrials.gov (identifier: NCT00433563). All participants provided written informed consent, and the study adhered to the ethical principles outlined in the Declaration of Helsinki and Good Clinical Practice guidelines. Ethical approval for the trial was granted by the National Research Ethics Service Committee Northwest\u2013Greater Manchester Central in the United Kingdom on December 21, 2007 (REC reference 07\/H1008\/229). The study protocol received approval from the institutional review board or research ethics committee at each participating country and study site.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}